TUBUTECAN
Live / Registered — Registered (as of 11 Aug 2026)
What this means for you
Registered since 11 Aug 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79418921
- Registration number
- 8386915
- Mark type
- Stylized text
- Filed
- 06 Feb 2025
- Published for opposition
- 10 Mar 2026
- Registered
- 11 Aug 2026
- Attorney of record
- Ryan D. Artis
Goods and services
- Class 001 — Chemicals: Chemical, biochemical, biological, and biotechnological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for industrial and scientific use; antibodies, fragments of antibodies and antibody-drug conjugates for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for laboratories, diagnostics and analytics for scientific or research use; chemical, biochemical, biological, and biotechnological preparations for industrial and scientific use.
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases, liver metabolic disorders and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; therapeutic pharmaceuticals, namely antibody-drug conjugates for the treatment of cancer and autoimmune diseases; pharmaceutical and veterinary preparations for the treatment of cancer and autoimmune diseases, comprising small molecules; small molecule compounds being pharmaceuticals for the treatment of cancer; all of the foregoing containing topoisomerase I inhibitor antineoplastics
- Class 042 — Scientific and technological services: Scientific and technological services, namely scientific research, analysis, testing and design in the fields of biology, chemistry and medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations, biomarker reagents and diagnostic apparatus
Owner
- Tubulis GmbH, DE
- Tubulis GmbH, DE
- Tubulis GmbH, DE
Prosecution history
- 10 Sept 2026 — LIMITATION OF GOODS RECEIVED FROM IB
- 03 Sept 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 12 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 12 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 11 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 19 Jul 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 16 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 02 Apr 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 13 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED